| INFLARX N.V. EO 0,12 |
| Niederlande |
| Gesundheit |
| NL0012661870 / A2H7A5 |
| IF0 (Frankfurt) / IFRX (NASDAQ) |
| FRA:IF0, ETR:IF0, IF0:GR, NASDAQ:IFRX |
| - |
| https://www.inflarx.de/ |
|
InflaRx N.V. is a clinical-stage biopharmaceutical..
>Volltext.. |
| 69.65 Mio. EUR |
| 22.5 Mio. EUR |
| - |
| - |
| - |
| - |
| 0.61 Mio. EUR |
| 13.2 Mio. EUR |
| - |
| 2.97 |
| - |
| - |
| - |
| - |
| - |
| - |
| INFLARX |
| 10.11.25 |